Search research articles
Contact Us
Filters
Showing results (231-240 of 254) with videos related to
Page
of 26
Sort By:
Vaccine
|
August 2, 2005
Expression of the Necator americanus hookworm larval antigen Na-ASP-2 in Pichia pastoris and purification of the recombinant protein for use in human clinical trials
Gaddam Narsa Goud, Maria Elena Bottazzi, Bin Zhan, et al.
NPJ Vaccines
|
July 21, 2024
A trivalent protein-based pan-Betacoronavirus vaccine elicits cross-neutralizing antibodies against a panel of coronavirus pseudoviruses
Syamala Rani Thimmiraju, Rakesh Adhikari, JeAnna R Redd, et al.
Biochimica Et Biophysica Acta. General Subjects
|
March 18, 2021
Genetic modification to design a stable yeast-expressed recombinant SARS-CoV-2 receptor binding domain as a COVID-19 vaccine candidate
Wen-Hsiang Chen, Junfei Wei, Rakhi Tyagi Kundu, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
April 22, 2009
An enzymatically inactivated hemoglobinase from Necator americanus induces neutralizing antibodies against multiple hookworm species and protects dogs against heterologous hookworm infection
Mark S Pearson, Jeffrey M Bethony, Darren A Pickering, et al.
Protein Expression and Purification
|
October 24, 2021
Yeast-expressed recombinant SARS-CoV-2 receptor binding domain RBD203-N1 as a COVID-19 protein vaccine candidate
Wen-Hsiang Chen, Jeroen Pollet, Ulrich Strych, et al.
Human Vaccines & Immunotherapeutics
|
April 13, 2021
SARS‑CoV-2 RBD219-N1C1: A yeast-expressed SARS-CoV-2 recombinant receptor-binding domain candidate vaccine stimulates virus neutralizing antibodies and T-cell immunity in mice
Jeroen Pollet, Wen-Hsiang Chen, Leroy Versteeg, et al.
Biorxiv : the Preprint Server for Biology
|
July 16, 2021
Receptor-binding domain recombinant protein on alum-CpG induces broad protection against SARS-CoV-2 variants of concern
Jeroen Pollet, Ulrich Strych, Wen-Hsiang Chen, et al.
Vaccine
|
May 14, 2022
Receptor-binding domain recombinant protein on alum-CpG induces broad protection against SARS-CoV-2 variants of concern
Jeroen Pollet, Ulrich Strych, Wen-Hsiang Chen, et al.
Biorxiv : the Preprint Server for Biology
|
November 11, 2020
SARS-CoV-2 RBD219-N1C1: A Yeast-Expressed SARS-CoV-2 Recombinant Receptor-Binding Domain Candidate Vaccine Stimulates Virus Neutralizing Antibodies and T-cell Immunity in Mice
Jeroen Pollet, Wen-Hsiang Chen, Leroy Versteeg, et al.
Plos Neglected Tropical Diseases
|
March 10, 2017
Structure of SALO, a leishmaniasis vaccine candidate from the sand fly Lutzomyia longipalpis
Oluwatoyin A Asojo, Alan Kelleher, Zhuyun Liu, et al.
Page
of 26
Search research articles
Search
Showing results (231-240 of 254) with videos related to
Sort By:
Page
of 26
Vaccine
|
August 2, 2005
Expression of the Necator americanus hookworm larval antigen Na-ASP-2 in Pichia pastoris and purification of the recombinant protein for use in human clinical trials
Gaddam Narsa Goud, Maria Elena Bottazzi, Bin Zhan, et al.
NPJ Vaccines
|
July 21, 2024
A trivalent protein-based pan-Betacoronavirus vaccine elicits cross-neutralizing antibodies against a panel of coronavirus pseudoviruses
Syamala Rani Thimmiraju, Rakesh Adhikari, JeAnna R Redd, et al.
Biochimica Et Biophysica Acta. General Subjects
|
March 18, 2021
Genetic modification to design a stable yeast-expressed recombinant SARS-CoV-2 receptor binding domain as a COVID-19 vaccine candidate
Wen-Hsiang Chen, Junfei Wei, Rakhi Tyagi Kundu, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
April 22, 2009
An enzymatically inactivated hemoglobinase from Necator americanus induces neutralizing antibodies against multiple hookworm species and protects dogs against heterologous hookworm infection
Mark S Pearson, Jeffrey M Bethony, Darren A Pickering, et al.
Protein Expression and Purification
|
October 24, 2021
Yeast-expressed recombinant SARS-CoV-2 receptor binding domain RBD203-N1 as a COVID-19 protein vaccine candidate
Wen-Hsiang Chen, Jeroen Pollet, Ulrich Strych, et al.
Human Vaccines & Immunotherapeutics
|
April 13, 2021
SARS‑CoV-2 RBD219-N1C1: A yeast-expressed SARS-CoV-2 recombinant receptor-binding domain candidate vaccine stimulates virus neutralizing antibodies and T-cell immunity in mice
Jeroen Pollet, Wen-Hsiang Chen, Leroy Versteeg, et al.
Biorxiv : the Preprint Server for Biology
|
July 16, 2021
Receptor-binding domain recombinant protein on alum-CpG induces broad protection against SARS-CoV-2 variants of concern
Jeroen Pollet, Ulrich Strych, Wen-Hsiang Chen, et al.
Vaccine
|
May 14, 2022
Receptor-binding domain recombinant protein on alum-CpG induces broad protection against SARS-CoV-2 variants of concern
Jeroen Pollet, Ulrich Strych, Wen-Hsiang Chen, et al.
Biorxiv : the Preprint Server for Biology
|
November 11, 2020
SARS-CoV-2 RBD219-N1C1: A Yeast-Expressed SARS-CoV-2 Recombinant Receptor-Binding Domain Candidate Vaccine Stimulates Virus Neutralizing Antibodies and T-cell Immunity in Mice
Jeroen Pollet, Wen-Hsiang Chen, Leroy Versteeg, et al.
Plos Neglected Tropical Diseases
|
March 10, 2017
Structure of SALO, a leishmaniasis vaccine candidate from the sand fly Lutzomyia longipalpis
Oluwatoyin A Asojo, Alan Kelleher, Zhuyun Liu, et al.
Page
of 26